In the context of solid organ transplant, what does a positive crossmatch indicate?

In the context of solid organ transplant, what does a positive crossmatch indicate?

• A. It suggests the donor organ is not suitable for transplantation
• B. It indicates the presence of preformed anti-donor HLA antibodies
• C. It verifies the quality of the donor organ
• D. It confirms that the patient has no sensitization history

Answer: (B)

A positive crossmatch in the context of solid organ transplantation is significant, as it indicates the presence of preformed anti-donor HLA antibodies in the recipient's serum. This is a crucial aspect of transplant immunology because these antibodies can mediate an acute immune response against the transplanted organ. When a potential recipient's serum is mixed with donor lymphocytes during the crossmatch testing, the detection of these antibodies suggests that the recipient has been sensitized to the donor’s human leukocyte antigens (HLA). If these antibodies are present, it implies that the immune system may recognize the donor's cells as foreign and mount an attack against the transplanted organ, leading to graft rejection. Understanding this concept is key for transplant clinicians, as a positive crossmatch typically indicates that the donor organ is not suitable for transplantation unless specific strategies, such as desensitization protocols, are employed. The other choices do not accurately reflect the significance of a positive crossmatch; therefore, option B appropriately captures the critical role of preformed anti-donor HLA antibodies in the transplantation process.

A positive crossmatch in the context of solid organ transplantation is significant, as it indicates the presence of preformed anti-donor HLA antibodies in the recipient's serum. This is a crucial aspect of transplant immunology because these antibodies can mediate an acute immune response against the transplanted organ.

When a potential recipient's serum is mixed with donor lymphocytes during the crossmatch testing, the detection of these antibodies suggests that the recipient has been sensitized to the donor’s human leukocyte antigens (HLA). If these antibodies are present, it implies that the immune system may recognize the donor's cells as foreign and mount an attack against the transplanted organ, leading to graft rejection.

Understanding this concept is key for transplant clinicians, as a positive crossmatch typically indicates that the donor organ is not suitable for transplantation unless specific strategies, such as desensitization protocols, are employed. The other choices do not accurately reflect the significance of a positive crossmatch; therefore, option B appropriately captures the critical role of preformed anti-donor HLA antibodies in the transplantation process.